Pure Global
NCT05932238

Systane® Hydration PF and Systane® Hydration Preserved

Alcon Research·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Eye
Drug/Device/Intervention
Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Alcon Research
Location
Fort Worth, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
May 01, 2024
Enrollment
135 participants
Primary outcome

Mean overall IDEEL-Symptom Bother(SB) score - Group 1,Resultant overall CLDEQ-8 score - Group 2 and Group 3

Summary

The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance
 and safety of Systane Hydration Preservative Free (PF) in subjects experiencing dry eye
 symptoms (Group 1) and in contact lens (CL) wearers experiencing discomfort due to CL-related
 dryness (Group 2) and also Systane Hydration Preserved in CL wearers experiencing discomfort
 due to CL-related dryness (Group 3). Statistical analyses will be presented by group.

ICD-10 classifications
Ocular painAvulsion of eyeOther corneal deformitiesCorneal ulcerDry mouth, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05932238
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05932238 through Pure Global AI's free database. This phase not specified trial is sponsored by Alcon Research and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 135 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.